Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus.

J Clin Transl Endocrinol · 2019 · PMC6306692 · PMID 30619717

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

did not reach statistical significancep = 0.059so close (0.05 < p ≤ 0.1)

After the treatment with suvorexant, median SDNN increased significantly from 109.5 to 113.2 ms ( p = 0.044), and median CVR-R showed a tendency to increase, from 11.9% to 13.6%, although this did not reach statistical significance ( p = 0.059).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.